Related Experiment Video
Updated: Jan 20, 2026

Assessing the Coherence of Parents' Short Narratives Regarding their Child Using the Five-Minute Speech Sample Procedure
Published on: September 19, 2019
Maternal immune markers during pregnancy and child neurodevelopmental outcomes at age 20 months in the Seychelles
Jessica L Irwin1, Emeir M McSorley2, Alison J Yeates2
1University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, United States of America.
Insights
Maternal inflammation during pregnancy may impact child neurodevelopment. This study found links between inflammatory markers and developmental outcomes, though some associations were unexpected, requiring further investigation.
Area of Science:
- Reproductive immunology
- Developmental neuroscience
- Behavioral science
Background:
- Immune system dysregulation in pregnant individuals may affect fetal development.
- Existing human research on this maternal-fetal immune connection is limited.
- Understanding these links is crucial for prenatal health and child development.
Purpose of the Study:
- To investigate the association between maternal inflammatory markers during pregnancy and neurodevelopmental outcomes in offspring.
- To explore the impact of late-second/early-third trimester maternal inflammation on child development at 20 months.
- To identify specific inflammatory markers and their relationship with neurodevelopmental trajectories.
Main Methods:
- Utilized structural equation modeling to analyze data from 1453 mother-child pairs.
- Measured maternal inflammatory markers at 28 weeks gestation.
- Assessed child neurodevelopmental outcomes at 20 months of age.
Main Results:
- Several significant associations were identified between maternal inflammatory markers and child neurodevelopmental outcomes.
- The direction of some observed associations was contrary to initial hypotheses.
- Findings suggest a complex interplay between maternal immune status and offspring neurodevelopment.
Conclusions:
- Maternal immune markers in late pregnancy are associated with child neurodevelopmental outcomes.
- The specific nature and direction of these associations require further research.
- Confirming these findings is essential for understanding prenatal influences on child development.
Abstract:
Immune dysregulation during pregnancy may influence behavior and neurodevelopment in offspring, but few human studies have tested this hypothesis. Using structural equation modeling, we examined associations between maternal inflammatory markers at 28 weeks gestation and child neurodevelopmental outcomes at 20 months of age in a sample of 1453 mother-child pairs. We observed several associations between maternal inflammatory markers measured in the late second or early third trimester and child neurodevelopmental outcomes. The direction of association for some markers was unexpected. Further research is warranted to confirm and elucidate the exact nature of these findings.
Related Concept Videos
Predicting Reaction Outcomes
What is the Immune System?
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...

